rheumatoid arthritis
Conditions
Brief summary
Bone erosion change of width, depth and volume measured by HRpQCT after 12 months of subcutaneous tocilizumab
Detailed description
Number of participants with associated factors with erosion changes by HRpQCT (Associated therapeutic, clinical and biological response )ultrasound ...), Changes of Bone mineral density by DXA at the lumbar spine and proximal femur, Correlation Between clinical activity measured by various indices (Disease Activity Score 28, Clinical Disease Activity Iindex , Simplify Disease Activity Index , American College of Rheumatology - European League against Rheumatism: ACR EULAR) and ultrasound data., Changes of bone microarchitecture by tibia HRpQCT
Interventions
Sponsors
Centre Hospitalier Universitaire D Orleans
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone erosion change of width, depth and volume measured by HRpQCT after 12 months of subcutaneous tocilizumab | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of participants with associated factors with erosion changes by HRpQCT (Associated therapeutic, clinical and biological response )ultrasound ...), Changes of Bone mineral density by DXA at the lumbar spine and proximal femur, Correlation Between clinical activity measured by various indices (Disease Activity Score 28, Clinical Disease Activity Iindex , Simplify Disease Activity Index , American College of Rheumatology - European League against Rheumatism: ACR EULAR) and ultrasound data., Changes of bone microarchitecture by tibia HRpQCT | — |
Countries
France
Outcome results
None listed